project id: TCGA-SKCM; case submitter id: TCGA-FS-A4F0; source center: 23; state: released; a260 a280 ratio: 1.85; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.46; rna integrity number: 9.1; age at index: 67; days to birth: -24717; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1936; age at diagnosis: 24717; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T4a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2367.0; icd 10 code: C49.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: Yes; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2003; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3223; initial weight: 20.0; oct embedded: false; preservation method: Unknown; sample id: 04bf6f29-b99b-44bf-83be-f791372b8c1d; sample submitter id: TCGA-FS-A4F0-06A; portion id: efe61bb4-1452-4402-b3ba-3f88c9316cf7; portion submitter id: TCGA-FS-A4F0-06A-11; slide id: 4c24383c-2291-4c72-860e-98105d71c6b8; slide submitter id: TCGA-FS-A4F0-06A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 95.0; section location: TOP;